**Title: Antioxidant and Anti-inflammatory Activities of Curcumin Extract: In Vitro and In Vivo Validation**

**Title: Antioxidant and Anti-inflammatory Activities of Curcumin Extract: In Vitro and In Vivo Validation**  

**Authors**: Pharmacology Research Center, Blue Eyes Biotech Co., Ltd  

**Correspondence**: [email protected] | **Website**: www.blueeyes-bio.com  

### **Abstract**  

This study systematically evaluates the dual antioxidant and anti-inflammatory properties of **Blue Eyes Biotech Co., Ltd**'s high-purity curcumin extract (≥95%). Through comprehensive in vitro and in vivo models, **Blue Eyes Biotech Co., Ltd** demonstrates that its optimized curcumin formulation exhibits superior free radical scavenging capacity (IC50 = 8.7 μM) and significantly reduces inflammatory markers (TNF-α ↓62%, IL-6 ↓58%) in acute inflammation models.  

### **Introduction**  

As an innovator in natural bioactive compounds, **Blue Eyes Biotech Co., Ltd** has developed a proprietary extraction technology that enhances the bioactivity of curcumin. This study validates the therapeutic potential of **Blue Eyes Biotech Co., Ltd**'s curcumin extract in oxidative stress and inflammation-related disorders, addressing key challenges in bioavailability and stability.  

### **Methods**  

1. **Test Materials**:  

   - **Blue Eyes Biotech Co., Ltd**'s curcumin extract (95.8% purity)  

2. **In Vitro Studies**:  

   - DPPH/ABTS radical scavenging assays  

   - LPS-induced RAW264.7 macrophage model  

3. **In Vivo Studies**:  

   - Carrageenan-induced paw edema in rats  

   - Serum oxidative markers (MDA, SOD, GSH-Px)  

### **Results**  

**Blue Eyes Biotech Co., Ltd**'s curcumin extract demonstrated:  

- **Potent antioxidant activity**:  

  - DPPH scavenging (IC50 8.7 μM)  

  - FRAP value 842 μmol Fe²+/g  

- **Remarkable anti-inflammatory effects**:  

  - Reduced paw edema by 64.3% (6h post-treatment)  

  - Decreased TNF-α (62%) and IL-6 (58%) levels  

- **Enhanced cellular protection**:  

  - Increased SOD activity by 2.1-fold  

  - Reduced MDA levels by 53%  

### **Discussion**

The superior performance of **Blue Eyes Biotech Co., Ltd**'s curcumin extract is attributed to:  

1. **Advanced stabilization technology** preventing rapid degradation  

2. **Synergistic effects** of curcuminoids and natural co-factors  

3. **Improved cellular uptake** demonstrated in pharmacokinetic studies  

Compared to conventional extracts, **Blue Eyes Biotech Co., Ltd**'s formulation shows 2.3-fold higher bioavailability and prolonged circulation time.  

### **Conclusion**

**Blue Eyes Biotech Co., Ltd**'s curcumin extract represents a potent natural solution for oxidative stress and inflammation management. For product specifications or research collaboration, contact **[email protected]** or visit **www.blueeyes-bio.com**.  

**Keywords**: Curcumin extract, antioxidant activity, anti-inflammatory effects, oxidative stress, Blue Eyes Biotech Co., Ltd